BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 38503591)

  • 1. [Genitourinary complications after pelvic radiotherapy: Diagnosis and management].
    Dubois A; Freton L; Richard C; Haudebert C; Jezequel M; Hascoet J; Peyronnet B
    Prog Urol; 2023 Nov; 33(12):563-571. PubMed ID: 38783761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can high-dose-rate brachytherapy prevent the major genitourinary complication better than external beam radiation alone for patients with previous transurethral resection of prostate?
    Luo HL; Fang FM; Kang CH; Chuang YC; Chiang PH
    Int Urol Nephrol; 2013 Feb; 45(1):113-9. PubMed ID: 22972569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity.
    Devisetty K; Zorn KC; Katz MH; Jani AB; Liauw SL
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1060-5. PubMed ID: 20045267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity.
    Ishiyama H; Kitano M; Satoh T; Kotani S; Uemae M; Matsumoto K; Okusa H; Tabata K; Baba S; Hayakawa K
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):23-8. PubMed ID: 19243900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genitourinary toxicity in patients receiving TURP prior to hypofractionated radiotherapy for clinically localized prostate cancer: A scoping review.
    Neerhut T; Grills R; Lynch R; Preece PD; McLeod K
    Urol Oncol; 2024 Jun; 42(6):165-174. PubMed ID: 38503591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review.
    Ishiyama H; Hirayama T; Jhaveri P; Satoh T; Paulino AC; Xu B; Butler EB; Teh BS
    Am J Clin Oncol; 2014 Jun; 37(3):297-304. PubMed ID: 22706173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysis.
    Di Franco R; Borzillo V; Ravo V; Ametrano G; Cammarota F; Rossetti S; Romano FJ; D'Aniello C; Cavaliere C; Iovane G; Porricelli MA; Muto M; Berretta M; Facchini G; Muto P
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3563-3575. PubMed ID: 28925488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
    Kollmeier MA; Stock RG; Cesaretti J; Stone NN
    J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis.
    Di Franco R; Borzillo V; Ravo V; Ametrano G; Falivene S; Cammarota F; Rossetti S; Romano FJ; D'Aniello C; Cavaliere C; Iovane G; Piscitelli R; Berretta M; Muto P; Facchini G
    Oncotarget; 2017 Mar; 8(10):17383-17395. PubMed ID: 28129649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature.
    Budäus L; Bolla M; Bossi A; Cozzarini C; Crook J; Widmark A; Wiegel T
    Eur Urol; 2012 Jan; 61(1):112-27. PubMed ID: 22001105
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.